Category Archives: DTC Advertising

Welcome to my 500th posting! Yesterday the Government Accountability Office released a report related to a topic often discussed in this space – the lack of FDA enforcement, specifically with regard to DTC – entitled "Trends in FDA’s Oversight of … Continue reading →

The House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations held a hearing this morning entitled "Direct-to-Consumer Advertising:  Marketing, Education or Deception?"  This is further evidence that as the election cycle heats up the Congress is quite likely … Continue reading →

There is news out from the Direct Marketing Association  as reported by Pharmaceutical Executive that forecasts that as the result of a number of events and issues, Direct-to-Consumer (DTC) marketing is poised to pick up quite a bit this year … Continue reading →

Yesterday I noted that there were letters flowing down from the Hill to manufacturers regarding some specific examples of Direct-to-Consumer (DTC) ads that were of interest to various members for various reasons.  Today, the Los Angeles Times carries a report … Continue reading →

The flurry of paper trailing down Capitol Hill to various folks working in and regulating the pharmaceutical industry continues.  Recently members of both the House and the Senate have sent letters to manufacturers of treatments that have lately been in … Continue reading →